Uganda Approves Twice Yearly HIV Prevention Drug Lenacapavir
The National Drug Authority (NDA) has formally approved the use of lenacapavir, a twice-yearly injectable HIV prevention drug, marking ...
- Latest
![](<a href="https://www.stanbicbank.co.ug/uganda/personal/about-us/our-community-investment" target="_blank" rel="noopener"> <img src="https://softpower.ug/wp-content/uploads/2025/12/Deo-Bakery-RM_728x90-scaled.png" alt="Stanbic Bank Community Investment"> </a>)
The National Drug Authority (NDA) has formally approved the use of lenacapavir, a twice-yearly injectable HIV prevention drug, marking ...
Johannesburg — UNAIDS Executive Director Winnie Byanyima has issued a powerful call for urgent, fair, and affordable access to the ...
The United States has announced plans to introduce lenacapavir, a groundbreaking HIV prevention drug, in Uganda as part of its ...
![Tuko Pamoja Docuseries](<a href="https://www.stanbicbank.co.ug/uganda/personal/about-us/our-community-investment" target="_blank" rel="noopener"> <img src="https://softpower.ug/wp-content/uploads/2025/12/Family-_728x90-scaled.png" alt="Stanbic Bank Community Investment"> </a>)
SoftPower News is a subsidiary of SoftPower Communications LLC, a Ugandan digital media group. Keep posted of the latest from Uganda and East Africa.
Plot 4B Malcolm X, Kololo
P.O Box 1497, Kampala - Uganda
Tel: +256-392-001-701
Email: info@softpower.ug
This news site is licenced by Uganda Communications Commission (UCC)